We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abingdon Health Plc | LSE:ABDX | London | Ordinary Share | GB00BLF79J41 | ORD 0.025P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.50 | 10.00 | 11.00 | 10.50 | 10.50 | 10.50 | 30,565 | 08:00:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.05M | -3.45M | -0.0284 | -3.70 | 12.78M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/12/2021 10:18 | If the Dolts in charge of this and ODX can't jump on the testing bandwagon now then they are not fit to be running anything. The success of these companies has more to do with politics-BJs UK Science agenda and all that. If the CEOs haven't been on the phone to local MPs and relevant ministers and the press and the SNP (they are usually quite good at making noise, esp if they suspect Tory contacts maybe getting bungs from Chinese connections to take billions of LFTs into the UK)then they should be running the local CO-Ops where they live instead and let people in who can save their employees' jobs. | cumnor | |
31/12/2021 09:46 | If you feel it's coming...get a box of tissues....... | badger60 | |
30/12/2021 20:10 | Been a while with no substantial news here I feel it's coming. Also this is certainly a good bet given test shortages ATM :) I've added a few today and yesterday. Still holding about £30k with an average of 50's but my overall average is now 37p :):):) | g2theary | |
30/12/2021 20:08 | Ha! What a bent badger ? | g2theary | |
30/12/2021 13:21 | This share price is stalled Bojo n co have betrayed British diagnostic companies 🥵🥵 | global_specials_real_dad | |
30/12/2021 13:18 | Hello everyone | global_specials_real_dad | |
30/12/2021 13:13 | Thats a lot of tests "Health Secretary Sajid Javid says the government will triple the supply of lateral flow tests to 300 million per month by February, but added that as current shortages persist "we expect to need to constrain the system at certain points over the next two weeks". | riddlerone | |
30/12/2021 09:45 | Bye bye..... | badger60 | |
30/12/2021 08:22 | BUY BUY BUY ;) | g2theary | |
29/12/2021 23:53 | https://apple.news/A | g2theary | |
29/12/2021 19:59 | Does the taxpayer foot the bill for all these tests? | cottlet | |
29/12/2021 16:56 | Please stop this self serving nonsense. There isn't an LFT rapid antigen test manufactured by Abingdon or originated in the UK that the UKHSA could buy even if it wanted to, and it doesn't yet. It's why the UKHSA announced a tender for another 800mln of Chinese tests to be supplied, commencing January. Note: Chinese. Abingdon has no volume manufacturing contract for any LFT rapid antigen tests; Omega look better positioned to stay afloat longer albeit both will continue to diminish in value, true to trend. Stay short. Price target is 18p. | shallow pockets | |
29/12/2021 16:26 | 90p early next year as in the 1st week ;););) | g2theary | |
29/12/2021 13:02 | UK Gov looking for an LFT supplier! Not long now. | david gruen | |
29/12/2021 11:18 | This will hit 40p very shortly :););):);) | g2theary | |
29/12/2021 10:31 | Pharmacists are warning of patchy supplies of rapid Covid tests following changes to self-isolation rules. Free-to-order rapid tests are seen as a crucial way to keep safe as Covid cases surge. Countries like the US have scrambled to follow the UK's lead in providing mass lateral flow tests free of charge | megsta | |
22/12/2021 15:53 | yes ...around midday i think (II) | jaf111 | |
22/12/2021 14:09 | Nothing on HL. | david gruen | |
22/12/2021 14:08 | Anyone got their placing shares yet? | guy gibson | |
22/12/2021 13:47 | This is all nonsense and drivel chat by those already long and talking their books, sorry to say. Lots of other tests have also got CE mark self test approval, and several of the others have secure market share, of which Avacta has none. It's unlikely to gain any either, as it lacks UKHSA integrity and PD evaluation. Not least it can't compete with the Acon's and Healgens on price. Calm down and see Abingdon for what it is: a company that built the house highly capital intensively and expected the customers to come. They haven't. They won't. This stock is on a death spiral to receivership or such a low price to book value (my guess is low teens) that someone picks up the assets cheaply. Short. | shallow pockets | |
22/12/2021 12:39 | Needs an eod close above 33.9 to confirm the double Bottom Target price 39.0 | bamboo2 | |
22/12/2021 11:42 | Huge volume | someuwin | |
22/12/2021 10:29 | Massive opportunity here- market cap is crazy given the news almost certain to arrive imminently | f3rdinand | |
22/12/2021 10:27 | oh yeah NT at 33p now spike baby spike | dave4545 | |
22/12/2021 10:21 | I can only assume Abingdon's revenues going forward will benefit from Avacta's news today, which is especially comforting for those shareholders who went fo a big excess in the open offer. It seems that there will be scale back to around 55% on the excess application shares, I thought it would be more! | timbo003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions